Patent Yard Sign in
Expired Canadian patentCanada

Tablet containing 3-(2-{4-(hexyloxycarbonylamino-imino-methyl)-phenylamino-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino-propionic acid ethylester or the salts thereof

CA 2535810 C · Owner: Boehringer Ingelheim International Gmbh · Inventors: Kohlrausch, Anja

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention relates to a new tablet for the active substance ethyl 3-(2-{4-(hexyloxycarbonylamino-imino-methyl)-phenylamino-methyl}-1-methyl- 1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino-propionate and the pharmacologically , acceptable salts thereof.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 10, 2004 and granted June 25, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 10, 2024.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 10, 2026.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 10, 2004
GrantedJune 25, 2013
Term endedAugust 10, 2024
Patent numberCA 2535810 C
Classification (IPC)A61K9/20

Timeline

Timeline From CIPO dates

2005200720092011201320152017201920212023Application filedAug 10, 2004Patent grantedJune 25, 2013Term endedAug 10, 2024

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.